Rationale, design, and methods for a Coreg (carvedilol) Heart Failure Registry (COHERE)

This publication has 16 references indexed in Scilit:

• Can physicians always explain the results of clinical trials? a case study of amlodipine in heart failure
  The American Journal of Cardiology, 1999
• Congestive Heart Failure in the Community
  Circulation, 1998
• Use of angiotensin-converting enzyme inhibitors at discharge in patients with acute myocardial infarction in the United States: data from the National Registry of Myocardial Infarction 2
  Journal of the American College of Cardiology, 1998
• Heart failure in the community
  Progress in Cardiovascular Diseases, 1998
• Run-in Periods in Randomized Trials
  Published by American Medical Association (AMA) ,1998
• The Effect of Carvedilol on Morbidity and Mortality in Patients with Chronic Heart Failure
  New England Journal of Medicine, 1996
• Conclusions. 1: The relationship between clinical trials and clinical practice: The risks of underestimating its complexity
  Statistics in Medicine, 1994
• Studies of left ventricular dysfunction (SOLVD) registry: Rationale, design, methods and description of baseline characteristics
  The American Journal of Cardiology, 1992
• Congestive heart failure symptoms in patients with preserved left ventricular systolic function: Analysis of the CASS registry
  Journal of the American College of Cardiology, 1991
• Acute Myocardial Infarction: One Year Follow‐up of 1138 Cases from the Perth Community Coronary Register
  Australian and New Zealand Journal of Medicine, 1976